Utilizing a novel light-based method for heart rhythm management, the technology employs optogenetic gene therapy alongside an implantable micro-LED array to create an Optic Defibrillator that painlessly addresses Atrial Fibrillation by stopping chaotic contractions with precise light pulses. This innovative solution overcomes existing treatment limitations, aiming for better long-term rhythm control and improved patient outcomes.